Skip to main content
. 2019 Dec;47(12):1403–1414. doi: 10.1124/dmd.119.088716

TABLE 7.

The Kp and Kpuu values predicted from the compartmental BBB model describing the brain and plasma concentration-time profile following either intravenous or oral administration of SAR405838

Route of Administration Intravenous Oral Mdr1a/b−/− Bcrp1−/−
Wild Type Mdr1a/b−/− Bcrp1−/− Wild Type Bcrp1−/− Mdr1a/b−/−
AUC0→∞, plasma 15,915 15,915 63,748 63,955 63,503 64,165
AUC0→∞, brain 404 11,462 1243 1859 71,308 68,317
Kppreda 0.025 0.72 0.019 0.029 1.12 1.06
DApredb 28 1.5 58 55
Clin 0.131 0.131 0.138 0.138 0.138 0.138
Clout 5.1 0.181 7.1 4.7 0.118 0.126
CLin/CLoutc 0.026 0.72 0.019 0.029 1.17 1.10
DApredd 28 1.5 60 56
a

Kppred, the ratio of model predicted AUC0→∞, brain to model predicted AUC0→∞, plasma.

b

DApred (distribution advantage), the ratio of Kpknockout to Kpwild-type.

c

The ratio of model predicted clearance into the brain to model predicted clearance out of the brain compartment.

d

DApred (distribution advantage), the ratio of brain clearance ratio in wild-type to brain clearance ratio in transgenic mice.